Cellmid Limited (ASX:CDY) director Maria Halasz has demonstrated her confidence in the company with the purchase of 39,000 indirect shares at 21 cents a share in on-market trades.
The managing director and chief executive officer increased her holding to 1,585,938 fully paid ordinary shares.
Last month the company registered its évolis Professional anti-ageing hair care products for sale in the European Union and the UK.
This represented the final step in a comprehensive regulatory compliance assessment of the products before they could be freely sold in Europe.
Cellmid also established a partnership with one of the largest cosmetics retailers in Europe and expects e-commerce sales on the partner’s platform will begin in the first half of the 2020 financial year.
The évolis Professional product range of all 11 SKUS will be sold in EU member states by Cellmid’s cosmetic retail partner.
Consistent with the company’s strategic plan released to the market at the end of February, the EU product registration represents yet another important milestone in the company’s plans for the global expansion of the évolis brand.